The Dorset Formulary has been developed in associations with NHS Dorset Clinical Commissioning Group Dorset County Hospital NHS Foundation Trust Dorset Healthcare University NHS Foundation Trust Poole Hospital NHS Foundation Trust Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Emerade (adrenaline) Syringes- Medicines defect information
Bausch & Lomb UK limited has informed health care professionals of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.Patients and their carers, who have been supplied with an Emerade device should always carry two in-date adrenaline autoinjectors with them at all times. For more information please refer to medicines defect information.
Important drug supply issue affecting Salbutamol 2mg/5ml syrup
For patients who do not have sufficient supplies to last until early August, clinicians should consider prescribing alternative options during this time including unlicensed supplies of Salbutamol 2mg/5ml syrup. Clinicians will need to work with local pharmacies to understand more about the specific unlicensed products that can be sourced. Clinicians should refer to the UKMI memo for further advice if an unlicensed supply of Salbutamol 2mg/5ml syrup is considered unsuitable.
FreeStyle Libre® is AMBERon the Dorset formulary and therefore, following secondary care initiation, may be prescribed in primary care.
Pfizer Epanutin® (phenytoin) 30mg/5ml oral suspension will be out of stock from the week commencing 10 June 2019 until late July 2019.
Getting started: Use the search tool to find medicine of interest or browse by BNF chapter using the 'Chapters' Menu at top of page.
The Dorset Formulary aims to provide information on medicines supporting safe, evidence-based, cost-effective practice. Whilst the formulary contains links to relevant policies and guidelines, the prescriber retains the responsibility for the appropriate use of this information.
For further information on the development of the Dorset Formulary and participating organisations, please go to the About page.
Comments about any aspect of the formulary can be made by using the feedback tab at the top of this page.